Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844129 · ClinicalTrials.gov registry record
Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 112
- Enrollment target
NCT00844129: Completed study, sponsored by University of Utah.
NCT00844129 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00844129 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the incidence and clinical history of neurofibromatosis type 1-related spinal abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-12 |
What the finished NCT00844129 record still lists
NCT00844129 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00844129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00844129 about?
NCT00844129 is a clinical study titled "Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)". The purpose of this study is to determine the incidence and clinical history of neurofibromatosis type 1-related spinal abnormalities.
What is the current status of trial NCT00844129?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2006-12. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT00844129?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia